A groundbreaking study reveals that combining two drugs significantly boosts survival for men with high-risk, recurring prostate cancer. This dual therapy, now readily available in India, effectively ‘starves’ the disease by suppressing testosterone….
40% boost in survival for men: Pairing two cancer drugs may reduce prostate cancer death risk
